Form EFFECT Monopar Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 17, 2024 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATED: DARPA Selects IonQ to Produce Next-Generation Atomic Clocks
- Trip.com Group Releases 2025 Sustainability Report, Announces New Global Paid Paternity Leave Policy
- A robot wins Industrial Truck of the Year – and redraws the pallet-jack category
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
